Biotechnology Companies in United States (US)
Location
Category
List of Biotechnology companies in United States (US)
633 companies
Sort by
With over 200 completed projects and a team of experienced molecular biologists, P.I.CelKem accelerates innovation and supports the growth of local biotech talent. We are currently expanding our portfolio to include biomolecule reagents, assay kits, and imaging products, furthering our commitment to advancing scientific discovery.
Our focus on functional coatings and materials science allows us to address complex challenges and drive innovation in demanding applications. With a team of experienced scientists and engineers, BienaTech is dedicated to accelerating the adoption of sustainable materials and technologies, contributing to a more resilient and efficient future economy.
Light-Hope Diagnostics is committed to saving lives and reducing the global burden of cancer by making timely and affordable diagnostics available to everyone, worldwide. With a multidisciplinary team of experienced scientists, clinicians, and business leaders, we are driving the future of cancer diagnostics, building upon decades of combined expertise in molecular diagnostics, venture investment, and entrepreneurship.
We’ve established a reputation for transforming athletes through a systematic, science-backed methodology, as evidenced by testimonials from athletes across various levels of competition. We are committed to providing a data-driven, results-oriented experience, guaranteeing a measurable improvement in performance or your money back.
We work collaboratively with scientists and growers globally, delivering environmentally friendly solutions that improve ROI and contribute to sustainable food production. Cytozyme’s commitment to scientific advancement and practical application ensures growers can achieve healthier, stronger plants and maximize their harvests.
FasTrain Courses is a Vancouver-based training provider specializing in comprehensive professional development for the bio/pharmaceutical and biotech industries. We deliver interactive online courses designed to meet stringent FDA, EMA, and other regulatory agency training requirements. Our experienced instructors, practicing professionals, offer practical knowledge and solutions to help companies in the global market. We focus on solving technical and regulatory challenges, providing a competitive edge for small, medium, and large organizations involved in product development.
FasTrain Courses offers a wide range of courses, including CMC, sourcing biological raw materials, forced degradation, stability testing, and statistical methods. Our commitment is to provide flexible, accessible training that saves time and reduces travel costs.
Our key differentiators include our experienced instructors, stand-alone session format, and readily available recordings, ensuring flexibility for busy professionals. We also offer a comprehensive certification program and ongoing updates on cGXP regulations.
Nectero Therapeutics is a clinical-stage biotech company based in Tempe, Arizona, dedicated to transforming the treatment of aneurysmal disease. We are pioneering novel therapies, specifically the Nectero EAST ® System, to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms (AAA). Our approach utilizes an endovascular technique to deliver a proprietary mixture, minimizing the need for major intervention like EVAR or open surgery. Led by a highly accomplished, multidisciplinary management team and supported by renowned physician leaders, Nectero Therapeutics is committed to improving patient outcomes and extending lives.
The Nectero EAST ® System offers a promising alternative for patients with AAAs that may not otherwise qualify for traditional treatment options. By strengthening the aortic tissue around the aneurysm, we aim to significantly delay or prevent the need for invasive procedures. We are focused on developing innovative solutions to address a significant public health concern.
Nectero Medical, Inc. (DBA Nectero Therapeutics) is at the forefront of this research, driven by a passion for advancing vascular medicine and providing hope for patients and their families. We are dedicated to rigorous clinical development and regulatory compliance, ensuring the safety and efficacy of our therapies.
Immunowake, Inc. is a biotechnology company based in Birmingham, Alabama, specializing in cancer drug discovery. We are dedicated to developing safe and effective cytokine immune modulators, aiming to overcome tumor immune suppression and reactivate the patient’s own immune system to identify and eliminate cancer cells. Our approach, reflected in our name ‘Immunowake,’ focuses on ‘awakening’ the immune system to offer renewed hope. We leverage a robust research platform and a strong research pipeline to treat both cancer and autoimmune diseases.
Our core technology centers on precisely delivering cytokines to maximize their anti-tumor potential while minimizing systemic toxicity. This innovative strategy utilizes cytokines – key players in coordinating immune cell activation – to effectively combat cancer.
Immunowake is building a powerful pipeline of immune cytokine therapies, and recently secured investment from Haiju Talent Investment Fund, further solidifying our position at the forefront of cancer immunotherapy.
We are focused on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor, a protein implicated in a broad range of disease states including cancer metastasis and certain immunological conditions.
Leronlimab’s unique competitive inhibition of the CCR5 receptor offers a paradigm-shifting therapeutic approach, differentiating it from other CCR5 antagonists.
CytoDyn’s commitment is to enhancing the lives of patients through targeted medicine, leveraging the potential of leronlimab across multiple disease areas.
We are pioneering a revolutionary approach to cardiovascular health, targeting the genetic drivers of vascular decline with precision RNA medicines. Our core technology, including Target-Site Blockers (TSBs) and Antisense Oligonucleotides (ASOs), aims to restore vascular health and extend cardiovascular healthspan.
Cardivia Labs’ proprietary miRNA-targeting strategy and cell-specific vascular targeting offer a unique advantage in developing therapies for conditions like atherosclerosis and vascular aging. Our team, led by scientist-founder Ismail Cimen, is dedicated to translating cell-targeted RNA therapeutics into impactful treatments.
Currently, we are advancing programs targeting CXCR4, SIRT6, and TET2, with an IND-enabling study planned for CXCR4-TSB. We are committed to transforming outcomes for millions at risk of heart attack and stroke.
We empower individuals and healthcare providers to make more informed decisions about their health through accessible and affordable precision medicine solutions. Our TargetRichTM enrichment technology and next-generation sequencing capabilities provide comprehensive genetic insights.
Kailos Genetics combines robust next generation sequencing with illuminating, high-powered analytics to produce accurate and comprehensive genetic information. We offer a complete sequencing solution, from assay design to data analysis, and integrate seamlessly into existing laboratory workflows.
Founded in 2010, Kailos Genetics is committed to advancing precision medicine and improving patient outcomes.
We support a diverse ecosystem of companies, from startups to multinational corporations, fostering innovation and collaboration across the sector.
NCLifeSci delivers critical policy and advocacy leadership, drives workforce development programs, and provides invaluable industry connections, enabling our members to thrive in a global marketplace. We champion policies that encourage growth and support a strong life sciences workforce, ultimately contributing to economic opportunity and improved quality of life.
As the leading voice for North Carolina’s life sciences, we are committed to building a vibrant and successful industry for years to come.
Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.
Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.
Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.
Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.
Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
We leverage the power of quantum computing to revolutionize drug discovery, compressing the lead time for pre-clinical drug candidates from five years to just four months. This allows us to generate up to 100 drug blueprints annually, enabling rapid adaptation within the precision medicine market.
PolarisQB’s unique approach utilizes Quantum Annealing and Quantum Inspired Algorithms to explore a chemical space far exceeding the capabilities of traditional methods – over 10^30 chemical spaces compared to the limitations of conventional screening. We are dedicated to accelerating the development of novel therapeutics and personalized medicine solutions.
Founded in 2020, PolarisQB is rapidly establishing itself as a leader in computational chemistry, with a team of experts and a growing portfolio of intellectual property. We collaborate with pharmaceutical, biotech, and agricultural companies to unlock the potential of quantum computing for drug design.
Following the merger with Idera Pharmaceuticals in 2022, Aceragen is dedicated to advancing its pipeline of novel treatments, particularly in the area of rare genetic diseases. We leverage a patient-centric approach, combining scientific expertise with a deep understanding of the challenges faced by patients and their families.
Aceragen’s core expertise lies in the development of targeted therapies, utilizing innovative technologies to address unmet medical needs. We are committed to improving the lives of patients and their families through the discovery and delivery of transformative medicines. Our team combines decades of experience in drug development, manufacturing, and commercialization, ensuring a robust pathway to market for our promising therapies. We operate with a strong focus on ethical practices and patient well-being.
We’re building on the pioneering tissue regeneration research of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos, leveraging their groundbreaking work to develop innovative implant solutions.
CytexOrtho’s approach focuses on regrowing cartilage and repairing damaged joints, offering a potential alternative to traditional hip replacements and addressing the growing market for osteoarthritis treatment. Our commitment to advancing patient care drives our research and development efforts, aiming to provide effective and lasting solutions for individuals suffering from joint pain.
Currently, our products are in development and not yet approved by the FDA or commercially available. We are focused on bringing this transformative technology to market, contingent upon regulatory approval.
We transform crop protection with rapid development of new products based on innovative, novel peptides and RNAi that are tailor-made to the needs of farmers. Our core technology, EvoStat, enables the evolution of these products to combat potential pest or pathogen resistance, offering a long-term and cost-effective solution for farmers.
Backed by a team of experienced scientists and significant venture capital funding, Innatrix is committed to empowering farmers to increase yields by at least 10% while achieving a return on investment exceeding 3x. We are focused on providing robust, sustainable solutions to the challenges of crop protection.
Currently, we are developing InnaLB™ for potato late blight, InnaNema™ for soybean cyst nematode, and InnaHLB™ for citrus greening.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
We support companies and organizations across the agricultural biotechnology sector, including seed producers, technology providers, and biotech associations, by offering comprehensive programs focused on transgene technology management, genome editing stewardship, and broader plant breeding innovation.
Our approach centers on flexibility, adaptability, and accessibility, ensuring that our programs integrate seamlessly into existing systems and provide valuable guidance to organizations of all sizes. We help ensure quality products reach the market, fostering trust with growers and consumers through robust stewardship practices.
Founded in 2008 as Excellence Through Stewardship, we’ve grown to encompass the Global Stewardship Group, reflecting our expanded scope of services and commitment to a more sustainable and responsible biotechnology landscape.
We specialize in developing and delivering innovative biological solutions for growers seeking to improve crop yield, quality, and overall profitability. Bontera’s approach centers on harnessing the power of naturally-occurring soil microbes – including Bacillus, Trichodermas, and Rhizobium – to create robust root development, increased nutrient availability, and enhanced plant health.
Our custom blend solutions and market-ready products are 100% organically derived, compatible with sustainable and organic growing practices, and represent a commitment to nurturing land health for future generations. We work with growers to tailor microbial blends to specific crop and soil needs, supporting a more resilient and productive agricultural ecosystem.
Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.
BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.
We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.
We provide a comprehensive selection of fittings, connectors, tubing, and flow control equipment, ensuring researchers and engineers have the essential components for their experiments and manufacturing processes. Our commitment to rapid order fulfillment from our Irvine facility allows you to focus on innovation, while our diverse product range caters to a wide spectrum of applications.
ELEXAN Scientific is your trusted partner for reliable, high-quality microfluidic solutions, supporting advancements across biotechnology research and beyond. We strive to streamline your sourcing experience, empowering you to push the boundaries of discovery.
We are dedicated to revolutionizing the treatment of life-threatening viral infections and cancer by addressing a previously overlooked vulnerability: the presence of harmful autoantibodies that impair the immune system’s ability to combat viruses or respond effectively to anticancer therapy.
Micoy Therapeutics develops targeted therapies and companion diagnostics, including the NeuroLume™ rapid test for Folate Receptor Autoantibodies (FRAAs) and decoy biologics to neutralize Type I Interferon Autoantibodies. Our innovative approach combines immunology, protein engineering, and diagnostic innovation to detect and neutralize these autoantibodies early, restoring immune balance and protecting individuals from a wide range of viral threats.
Led by a team of experts in drug discovery, immunology, and translational medicine, Micoy Therapeutics is building a platform for immune health across the lifespan, revealing how autoantibodies shape human health and creating practical solutions to restore balance and resilience.
We connect top-tier professionals – including executive management, sales and marketing experts, and technical personnel – with innovative companies and established leaders across North America.
AchieveBio distinguishes itself through a consultative approach, deeply understanding client needs to deliver exceptional candidates. With 15 years of experience and an extensive network, we focus on identifying and securing those top contributors who drive business success.
Founded in 2008, AchieveBio is committed to ethical recruitment practices and building lasting relationships with both clients and candidates, ultimately helping organizations achieve their strategic goals.
We understand the unique challenges faced by these emerging life sciences organizations – lean teams, aggressive timelines, and high-stakes trials – and offer a refreshingly professional approach to outsourcing.
As a results-driven global provider, Love Contracts, now Nova Outsourcing Management, leverages deep, hands-on experience from both the sponsor and CRO sides of the industry to deliver strategic outsourcing solutions, win-win negotiations, and strong vendor partnerships.
Led by Julia Love and Murtza Naseem, Nova helps companies maximize their investments and accelerate their clinical portfolios through innovative outsourcing strategies.
We cater to ambitious startup companies in the biotechnology research sector, offering a collaborative environment with top-of-the-line research equipment. Our goal is to accelerate resident companies’ milestones, reducing capital expenditure through shared resources and expert support.
BioLabs North Carolina simplifies the complexities of early-stage biotech development by offering a streamlined, supportive ecosystem. We are dedicated to fostering innovation and growth within the life sciences industry, connecting entrepreneurs with the tools and network they need to succeed.
Established in 2017, BioLabs North Carolina currently supports a team of 3 professionals and is strategically positioned to become a leading hub for biotech startups in the region.
CBio builds quality testing equipment and kits using novel separation science techniques, machine vision, and edge computing to ensure the life saving treatments will work as expected and are safe for patients to receive.
What sets CBio apart is our patented technology, which is able to identify microbial contamination and other quality issues such as detection of empty virus particles much faster than todays gold standard methods reducing weeks of testing time to within 48 hours.
Our transformative solution helps address critical issues affecting bio-manufacturing and quality testing to allow release of the powerful life saving treatments to patients when they need it most. We focus on diseases where effective treatments exist but remain out of reach because of cost, manufacturing complexity, or supply constraints. The science is solved. The access isn't.
We are pioneering the first human-derived antibody, designated GT103, to treat refractory non-small cell lung cancer (NSCLC). Our approach leverages exceptional outcomes observed in early lung cancer patients, isolating and engineering a novel antibody from patient B-cells using advanced molecular genomic techniques.
Grid Therapeutics is currently enrolling patients in a Phase 1 clinical trial, representing a significant step forward in personalized cancer treatment. We are dedicated to advancing innovative solutions for patients battling difficult-to-treat cancers.
Founded in 2014, Grid Therapeutics builds upon the groundbreaking research of Edward F. Patz, Jr. MD and his team at Duke University Medical Center, bringing decades of scientific expertise to the development of life-saving therapies.
We develop and manufacture the XCSITE 100, a leading tDCS/tACS research system, which is trusted by leading neuroscience labs across the United States. Our mission is to accelerate basic and translational neuroscience research by providing accessible and reliable tools.
Pulvinar Neuro is dedicated to supporting the advancement of neuroscience through continuous technological development and collaboration with the research community. We offer a range of products and services designed to meet the evolving needs of neuroscientists, fostering breakthroughs in understanding the brain.
Since launching the XCSITE 100 in 2016, we’ve grown to a team of 9, committed to pushing the boundaries of neurotechnology.
Our core offering centers around a proprietary platform that dramatically simplifies and optimizes the creation of high-quality, plant-derived reagents. This allows pharmaceutical companies and biotech firms to focus on their core research and development efforts, rather than being constrained by complex and costly reagent sourcing.
Founded in 2019, Tiamat Sciences is committed to driving sustainable innovation in the life sciences sector. We leverage cutting-edge biotechnology and a deep understanding of plant-based chemistry to deliver a superior alternative to traditional reagent production methods. We are dedicated to supporting the next generation of pharmaceutical products and fostering a more environmentally responsible industry.Plant-based reagents, pharmaceutical industry, biotechnology, sustainable innovation
We cultivate the highest quality, most tender meats – including prized cuts like filet mignon – without relying on animal agriculture. Our approach mirrors nature’s most efficient processes, utilizing bioreactors and cell scaffolds inspired by greenhouses and plant growth.
Myodenovo’s innovative technology offers a delicious and ethical alternative to traditional meat production, catering to discerning meat aficionados and contributing to a more sustainable food future. We are committed to providing a premium culinary experience while minimizing environmental impact.
We are dedicated to addressing a significant unmet need in the treatment of pink eye, a common condition affecting millions annually. Our lead product candidate, OKG-0303, is a ‘one-stop shop’ treatment for both bacterial and viral conjunctivitis, offering a comprehensive solution for healthcare professionals.
Okogen’s approach centers on a proprietary formulation combining antiviral, ocular decongestant, and antibacterial agents, aiming to simplify treatment and improve patient outcomes. With a growing market of $4.2 billion annually for conjunctivitis treatments, Okogen is positioned to become a leader in this space.
Currently, we are in Phase 2B clinical trials and have recently secured $3.3M in funding to advance our clinical program. Our team, led by CEO Joshua H. Moriarty and Chief Medical Officer David A. Hollander, brings extensive experience in ophthalmic pharmaceutical development.
Our mission is to empower parents and healthcare providers with the information they need to take meaningful steps during the critical early stages of development.
ASD Insight™ utilizes a revolutionary cellular biomarker detection technology, built on 8 years of robust academic research, offering a key factor supporting immediate action to learning about access to impactful interventions in children who are on the autism spectrum.
We’ve helped thousands of families gain clarity and access to vital support, and continue to expand our reach through strategic partnerships and ongoing research.
We support clients across a diverse range of industries – including alternative protein, biopharma, biofuels, and personal care – accelerating their development timelines with a focus on quality, velocity, and simplicity.
Growth Curve Bio provides critical infrastructure and expert support to companies navigating the complexities of precision fermentation, from early-stage research to scale-up. We help you streamline your processes and achieve faster, more reliable results.
Founded in 2023, our team of experienced scientists and engineers is dedicated to empowering innovation in the bioeconomy. We are committed to providing flexible, fee-for-service solutions tailored to your specific needs.
Company Name | Location | Category | Employees | Website |
|---|---|---|---|---|
Santa Clara, United States (US) | Science and Engineering Science and Engineering | 2-10 | http://www.asone-int.com/ | |
Rockville, United States (US) | Science and Engineering Science and Engineering | 200-500 | https://www.regenxbio.com | |
Wayne, United States (US) | Science and Engineering Science and Engineering | 20-30 | https://palvellatx.com/ | |
North Las Vegas, United States (US) | Science and Engineering Science and Engineering | 50-100 | http://www.sablesys.com | |
Parsippany, United States (US) | Science and Engineering Science and Engineering | 200-500 | http://www.canfieldsci.com | |
New York, United States (US) | Science and Engineering Science and Engineering | 10-20 | https://nr-s.net | |
Holly Springs, United States (US) | Science and Engineering Science and Engineering | 50-100 | http://www.planthealthcare.com | |
Coconut Creek, United States (US) | Science and Engineering Science and Engineering | 100-150 | https://www.reprotech.com | |
Boston, United States (US) | Science and Engineering Science and Engineering | 200-500 | http://www.crisprtx.com | |
Huntsville, United States (US) | Science and Engineering Science and Engineering | 500-1000 | http://www.dls.com | |
Tacoma, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.picelkem.com | |
Akron, United States (US) | Manufacturing and Industry +1 Manufacturing and Industry, Science and Engineering | 2-10 | https://bienatech.com/ | |
Salt Lake City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://lighthopediagnostics.com | |
Rochester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.liquidsportslab.com | |
Salt Lake City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | http://www.cytozymeag.com | |
Spokane, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://photonbiosciences.com/ | |
Huntsville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.vaxonyx.com/ | |
Worcester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | https://www.delaviesciences.com/ | |
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.reliantglycosciences.com/ | |
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://techcompartner.com/ | |
Vancouver, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://fastraincourses.com/ | |
Tempe, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | http://www.necteromedical.com | |
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | https://www.immunowake.com/ | |
VANCOUVER, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | https://www.cytodyn.com/ | |
Rochester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.cardivialab.com | |
Huntsville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | http://www.KailosGenetics.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.nclifesci.org/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://istarioncology.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.belhavenbio.com | |
RTP, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.polarisqb.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.aceragen.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://cytexortho.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.innatrix.com/ | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://aertherapeutics.com | |
Washington, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://excellencethroughstewardship.org | |
Dallas, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.bontera.com | |
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.bio-aesthetics.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://elexansci.com | |
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.micoytherapeutics.com/ | |
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://achievebio.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.novaoutsourcingmgmt.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.biolabs.io/location/north-carolina | |
Tampa, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.cbio.io | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.gridtherapeutics.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | https://www.pulvinarneuro.com/ | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.tiamat-sciences.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://myodenovo.com | |
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.okogen.com | |
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.neuroqure.com | |
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | http://www.growthcurvebio.com |
300/633 results
Frequently asked questions
Updated 23 October 2026
What is Enterprise League?
Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.
Is it free to list my company?
Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.
How does verification work, and what does it cost?
Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.
Where does the company information come from?
Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.
How do I claim or correct my company’s profile?
Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.